Galena Biopharma, Inc. (GALE):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82624FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Galena Biopharma, Inc. (Galena) is a biotechnology company. The company discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its products include Abstral, NeuVax, NeuVax Herceptin, and folate binding protein. The company provides NeuVax and NeuVax Hercepti for the treatment of breast cancer and folate binding protein for the treatment of endometrial and ovarian cancer. Galena’s Abstral is a sublingual tablets for the management of breakthrough pain in cancer patients of 18 years of age. It partners with academia, small companies, and large multinationals. Galena is headquartered in Lake Portland, Oregon, the US.

Galena Biopharma, Inc. Key Recent Developments

Dec 04, 2013: Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference
Nov 26, 2013: Galena Biopharma to present at the 25th annual Piper Jaffray Healthcare Conference
Nov 06, 2013: Galena Biopharma Reports Third Quarter 2013 Results
Oct 04, 2013: Galena Biopharma to Present at the 12th Annual BIO Investor Forum
Sep 23, 2013: Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

This comprehensive SWOT profile of Galena Biopharma, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Galena Biopharma, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Galena Biopharma, Inc. – Key Information
Galena Biopharma, Inc. – Overview
Galena Biopharma, Inc. – Key Employees
Galena Biopharma, Inc. – Key Employee Biographies
Galena Biopharma, Inc. – Key Operational Heads
Galena Biopharma, Inc. – Major Products and Services
Galena Biopharma, Inc. – History
Galena Biopharma, Inc. – Company Statement
Galena Biopharma, Inc. – Locations And Subsidiaries
Galena Biopharma, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Galena Biopharma, Inc. – Business Description
Galena Biopharma, Inc. – Corporate Strategy
Galena Biopharma, Inc. – SWOT Analysis
SWOT Analysis – Overview
Galena Biopharma, Inc. – Strengths
Galena Biopharma, Inc. – Weaknesses
Galena Biopharma, Inc. – Opportunities
Galena Biopharma, Inc. – Threats
Galena Biopharma, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Galena Biopharma, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Galena Biopharma, Inc., Key Information
Galena Biopharma, Inc., Key Ratios
Galena Biopharma, Inc., Share Data
Galena Biopharma, Inc., Major Products and Services
Galena Biopharma, Inc., History
Galena Biopharma, Inc., Key Employees
Galena Biopharma, Inc., Key Employee Biographies
Galena Biopharma, Inc., Key Operational Heads
Galena Biopharma, Inc., Other Locations
Galena Biopharma, Inc., Subsidiaries
Galena Biopharma, Inc., Key Manufacturing facilities
Galena Biopharma, Inc., Key Competitors
Galena Biopharma, Inc., SWOT Analysis
Galena Biopharma, Inc., Ratios based on current share price
Galena Biopharma, Inc., Annual Ratios
Galena Biopharma, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Galena Biopharma, Inc., Performance Chart
Galena Biopharma, Inc., Ratio Charts

★海外企業調査レポート[Galena Biopharma, Inc. (GALE):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nexant, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Nexant, Inc. Mergers and Acquis …
  • Cancer Therapeutics CRC Pty Ltd(製薬・医療分野):企業M&A動向
    Summary Cancer Therapeutics CRC Pty Ltd (Ctx) is a pharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer. The company’s research and development capabilities cover the full range of technologies and knowledge required to discover small molecule cancer dr …
  • Opnext, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Opnext, Inc. Mergers and Acquis …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業の財務及び戦略的SWOT分析
    Summary China Aviation Oil (Singapore) Corporation Ltd (CAO) a subsidiary of China National Aviation Fuel Group Corporation is an oil and gas company that offers jet fuel. The company operates through its business segments such as jet fuel supply and trading, trading of other oil products and invest …
  • MSC Konsult AB (MSC B):企業の財務及び戦略的SWOT分析
    Summary MSC Konsult AB (MSC) is a technology company that provides business development and consulting services. The company’s services include project and program management, IT architect, IT infrastructure, requirements and workshop line, systems development, testing and test management, and servi …
  • Atari S.A. (ATA):企業の財務及び戦略的SWOT分析
    Summary Atari S.A. (Atari) is a game product company that develops, publishes, and distributes interactive games software for different gaming consoles. The company offers gaming software that is compatible with Nintendo, Microsoft and Sony, along with other platforms. Its products provide various k …
  • Adira Energy Ltd. (ADENF):企業の財務及び戦略的SWOT分析
    Summary Adira Energy Ltd (Adira Energy) is an oil and gas exploration company that acquires and explores oil and gas resource properties. The company undertakes oil and gas projects in Israel. It holds interest in three offshore petroleum projects in Gabriella, Yitzhak and Samuel. Adira Energy partn …
  • Niko Resources Ltd. (NKO):企業の財務及び戦略的SWOT分析
    Summary Niko Resources Ltd. (Niko) is an oil and gas company that acquires, explores, develops and produces crude oil and natural gas. The company has interests of oil and gas properties in India, Indonesia, Bangladesh, Kurdistan, Madagascar, Pakistan and Trinidad, among others. It concentrates on v …
  • Clean Diesel Technologies, Inc. (CDTI):企業の財務及び戦略的SWOT分析
    Summary Clean Diesel Technologies, Inc. (CDTI) is a clean technology company that provides emission control solutions. The company offers heavy duty diesel products, catalyst products, alternative fuel products and standard exhaust and specialty products. It offers heavy duty diesel products such as …
  • FAR Limited (FAR):企業の財務及び戦略的SWOT分析
    Summary FAR Limited (FAR) is an oil and gas exploration company that provides exploration, development, production and acquisition of oil and natural gas. The company has pre-appraisal and exploration assets in West and East Africa. It also holds area surrounded by petroleum systems in West Africa. …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Merck Serono S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Merck Serono S.A. Mergers and A …
  • RF Surgical Systems LLC:企業のM&A・提携動向(医療機器分野)
    Summary RF Surgical Systems LLC (RF Surgical Systems) is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure detection system X, RF assure delivery system and RFDETECT premium. Its RF assures detection system X is used for det …
  • Global Green Matrix Corp. (formerly Poly-Pacific International, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Global Green Matrix Corp. (form …
  • National University of Singapore:企業のM&A・提携動向(医療機器分野)
    Summary National University of Singapore (NUS) is an educational institute that offers research and training services. The institute offers education services in areas which include arts and social sciences; business, computing, dentistry, design and environment; duke-NUS, engineering, integrative s …
  • Allied Hotel Properties Inc.:戦略・SWOT・企業財務分析
    Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Eloro Resources Ltd. (ELO):企業の財務及び戦略的SWOT分析
    Summary Eloro Resources Ltd. (Eloro Resources) is an energy company that offers mineral exploration services. The company acquires, explores and develops precious and base-metal resources in Quebec. It explores for silver, gold, iron, titanium, copper, vanadium, manganese, barium, and strontium, amo …
  • United Spirits Ltd:戦略・SWOT・企業財務分析
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Hitachi Zosen Corporation:企業の戦略・SWOT・財務分析
    SummaryHitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆